摘要
临床药师参与1例隐球菌脑膜炎患者的药物治疗过程,综合考量患者的个体因素,结合循证证据,参与患者抗感染药物治疗方案的调整,针对两性霉素B(Am B)致肾损伤进行分析及药学监护,保证患者治疗的有效性及安全性。
Clinical pharmacist participated in the drug treatment process of a patient with cryptococcal meningitis,and comprehensively considered the individual factors of the patient.Combining with evidence-based evidence,clinical pharmacist participated in the adjustment of the patient’s anti-infective drug treatment plan,analyzed and performed pharmaceutical monitoring for amphotericin B-induced renal damage.To ensure the effectiveness of treatment and the safety of medication,it is of great significance to improve the rational use of medication in clinical practice.
作者
杨莲娣
李淑娟
刘兆华
Yang Liandi;Li Shujuan;Liu Zhaohua(Hengyang Hospital of Traditional Chinese Medicine,Hengyang 421001,China)
出处
《中国药师》
CAS
2020年第11期2209-2212,共4页
China Pharmacist
关键词
临床药师
隐球菌性脑膜炎
两性霉素B
氟胞嘧啶
药品不良反应
药学监护
Clinical pharmacist
Cryptococcal meningitis
Amphotericin B
Flucytosine
Adverse drug reaction
Pharmaceutical care